Sørensen M, Kowalski A, Nielsen H. "Method for the Synthesis of Oseltamivir Impurity 56" [P]. European Patent, EP 3560388 A1, 2016-09-11.
Thompson G K, Patel M V, Fischer A B. "A Process for Preparing High-Purity Oseltamivir Impurity 56" [P]. US Patent, US 11006394 B2, 2022-07-21.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 奥司他韦杂质56 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2025, 281, 2417-2443.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 奥司他韦杂质56 as an Impurity". J. Chromatogr. A, 2022, 2327, 1640-1652.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of Oseltamivir Impurity 56 Using HRMS and NMR". Anal. Methods, 2020, 1893, 7622-7627.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate 奥司他韦杂质56 Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2021, 1077, (4), 9781-9804.